The association between delayed/sustained IFN signaling and disease outcome has also been postulated in the setting of acute viral infections like MERS-CoV and SARS-CoV-2 [75–77], indicating this may be a conserved feature of imbalanced or ineffective antiviral immunity. Here, IFNA1 is linked to viral infectious disease.